Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population
- PMID: 25355845
- PMCID: PMC4257749
- DOI: 10.1634/theoncologist.2014-0277
Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population
Abstract
This paper reports the first published prevalence of Multiple endocrine neoplasia type 2B (MEN 2B). Estimates of the epidemiology of MEN 2B were based on a single population with one centralized genetic clinic. MEN 2B remains a relatively rare condition and can be easily missed if the diagnosis has not been considered.
Figures
References
-
- Gertner ME, Kebebew E. Multiple endocrine neoplasia type 2. Curr Treat Options Oncol. 2004;5:315–325. - PubMed
-
- Moline J, Eng C. Multiple endocrine neoplasia type 2. Available at http://www.ncbi.nlm.nih.gov/books/NBK1257/. Accessed July 28, 2014. - PubMed
-
- Eng C, Smith DP, Mulligan LM, et al. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet. 1994;3:237–241. - PubMed
-
- Morrison PJ, Atkinson AB. Genetic aspects of familial thyroid cancer. The Oncologist. 2009;14:571–577. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
